URI names EpiVax founder to head Institute for Immunology & Informatics

Aiming to expand its reach into biomedical research and connect with clinicians, scientists and businesses in the state’s capital city, the University of Rhode Island has recruited a prominent vaccine researcher and built her a new lab in the Shepard Building downtown.

Dr. Anne S. De Groot, a longtime Brown University faculty member and the co-founder and CEO of Providence-based biopharmaceutical company EpiVax Inc., will lead the new Institute for Immunology and Informatics. Its goal is to use cutting-edge “bioinformatics” tools – sophisticated computer modeling – to develop vaccines against diseases identified as “neglected” by the research community, URI said.

Full Story: URI names EpiVax founder to head Institute for Immunology & Informatics Source: Providence Business News, February 12th, 2009 Author: Marion Davis

Related Items (4)

News (2)

New lab will research vaccines02.24.09Providence Journal
EpiVax founder to lead new university institute02.14.09Providence Business News

Companies / Organizations (2)